SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001178913-21-000912
Filing Date
2021-03-04
Accepted
2021-03-04 09:19:14
Documents
5
Period of Report
2021-03-04

Document Format Files

Seq Description Document Type Size
1 6-K zk2125707.htm 6-K 13169
2 EXHIBIT 1.1 exhibit_1-1.htm EX-99 325857
3 EXHIBIT 5.1 exihibt_5-1.htm EX-99 8542
4 EXHIBIT 5.2 exhibit_5-2.htm EX-99 8764
5 a.jpg GRAPHIC 3932
  Complete submission text file 0001178913-21-000912.txt   362796
Mailing Address 21 HA'ARBA'A STREET TEL AVIV L3 64739
Business Address 21 HA'ARBA'A STREET TEL AVIV L3 64739 972-3-541-3131
RedHill Biopharma Ltd. (Filer) CIK: 0001553846 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3
Type: 6-K | Act: 34 | File No.: 001-35773 | Film No.: 21712733
SIC: 2834 Pharmaceutical Preparations